Position in SANA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,264,091
-$897,519 QoQ
Shares Held
2,367,935
-25.6% QoQ
Ownership
0.791%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. SANA ranks #166 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in SANA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,264,091 | 2,367,935 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $9,161,610 | 3,181,115 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,057,694 | 1,488,377 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $2,421,426 | 682,092 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $827,828 | 303,234 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $929,719 | 553,405 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $1,637,580 | 1,004,651 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $3,535,990 | 849,998 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,462,654 | 817,336 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $8,527,760 | 852,776 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,387,590 | 830,292 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $2,378,664 | 614,642 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $5,121,123 | 859,249 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $3,191,826 | 976,094 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $7,364,766 | 1,864,498 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $8,465,208 | 1,410,868 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $5,472,102 | 851,027 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $4,917,087 | 595,289 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,029,351 | 389,493 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $6,155,278 | 273,325 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $7,234,643 | 367,988 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,247,627 | 156,786 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||